Category Archives: Health

19Oct/20

Stryker launches industry’s first completely wireless hospital bed

Stryker, one of the world’s leading medical technology companies, today announced the global launch of the industry’s first and only completely wireless hospital bed, ProCuity™. This intelligent bed was designed to help reduce in-hospital patient falls at all acuity levels, improve nurse workflow efficiencies and safety, as well as help lower hospital costs. It is the only bed on the market today that can connect seamlessly to nurse call systems without the use of cables or wires.  Read more

19Oct/20

MED-EL: First Surgeries Ever in Europe with a Totally Implantable Cochlear Implant

Leading hearing implant manufacturer MED-EL sets another revolutionary milestone in its long-standing history of technological innovations. On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI). It was implanted by Prof. Dr. Philippe Lefebvre, head of the ENT Department of the CHU of Liège and Professor at the University of Liège in Belgium within a feasibility study. The TICI is expected to give users great hearing with even more comfort. However, it will take several years before it receives market approval. Read more

21Sep/20

Axon Neuroscience to launch world’s first crowdfunded vaccine against COVID-19

AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more

08Aug/20

Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.1 SPRAVATO® is the first and only approved medicine that has been shown to reduce depressive symptoms within 24 hours,1 providing a new option for significant symptom relief until a longer-term, comprehensive treatment plan can take effect. Read more

02Aug/20

Brain Navi Develops New Robot Performing Nasal Swab Tests to Prevent Cross Infections

Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies. The coronavirus caused the lock-in policy over the world. To reopen and reboot the economy in this pandemic, a large scale of testing is the essential key and solution, but it needs to be done “safely and effectively.” With the Brain Navi Nasal Swab Robot’s assistance, users can test safely around the clock, so as to spare medical health care workers from the high-risk environment during sample collecting. With the unique robotic help, users can control the spread of the virus while waiting for a vaccine and prevent cross-infections. Read more

27Jul/20

University of Cambridge researchers and Huma begin in-depth study of early detection of COVID-19 infection

UK digital health and therapeutics company Huma is teaming up with the renowned Fenland Study research team at the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge to begin a study to understand the progression and early signs of COVID-19 infection. Read more

20Jul/20

Tech Leaders and Health Authorities from Around the Globe Collaborate to Combat COVID-19

he Linux Foundation, the nonprofit organization enabling mass innovation through open source, today launched a new initiative to use open source technologies to help public health authorities (PHAs) around the world combat COVID-19 and future epidemics. The new Linux Foundation Public Health (LFPH) initiative is launching with seven Premier members – Cisco, doc.ai, Geometer, IBM, NearForm, Tencent, and VMware – and two hosted exposure notifications projects, COVID ShieldTM and COVID GreenTM, which are currently being deployed in Canada, Ireland, and several U.S. states. Read more

19Jul/20

Frost & Sullivan Reveals Top Five Predictions for the Global Healthcare Industry Post COVID-19

Frost & Sullivan’s recent analysis, Post-Pandemic Global Healthcare Market Outlook, 2020, forecasts that 2020 will be an unforgiving but transformational year for the healthcare industry. As the world grapples with a global emergency caused by the COVID-19 pandemic, the healthcare industry is expected to witness a drop in growth from 5.3% to 0.6% in 2020, with revenues remaining below the $2 trillion mark. Read more

06Jun/20

Potential Life Saving COVID-19 Survival Manual Removed from Amazon Kindle Store Three Days before Official Launch

Dr. Steven Quay, MD, PhD, author and physician-scientist, announces the availability of his 158-page book, “Your COVID-19 Survival Manual: A Physician’s Guide to Keep You and Your Family Healthy During the Pandemic and Beyond,” in paperback and eBook format on his website, www.DrQuay.com, beginning Monday, June 8, 2020. Proceeds from the book will go to military veterans performing COVID-19 relief work in their communities. Read more